FDA official logo
GSRS logo
PFDA official logo

GOMILIXIMAB

  • UNII: 8Z13S29R5A
  • Preferred Substance Name: GOMILIXIMAB

  • 357613-86-6
  • GOMILIXIMAB [USAN]
  • IDEC-152
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER
  • LUMILIXIMAB
  • LUMILIXIMAB [INN]
  • LUMILIXIMAB [MART.]
  • LUMILIXIMAB [WHO-DD]
  • PRIMATIZED ANTI-CD23
  • ST-152

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.